Colitis asociada a rituximab

Barreiro Alonso, Eva; Álvarez Álvarez, Aranzazu; Tojo González, Rafael; Coba Ortiz, Cristóbal de la.
Gastroenterol. hepatol. (Ed. impr.) ; 42(4): 251-252, abr. 2019. ilus
Artículo en Español | IBECS (España) | ID: ibc-183401

Documentos relacionados

  1. The aggravating fury rituximab obliterated.
  2. A tale of two antibodies: obinutuzumab versus rituximab.
  3. A case of polymorphic dermal angiitis in a B-cell chronic lymphocytic leukemia patient during rituximab therapy.
  4. Rituximab-associated colitis.
  5. Kaposi sarcoma associated with rituximab-based cytotoxic therapy.
  6. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.
  7. B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
  8. Real-world use and acceptance of rituximab biosimilars in non-Hodgkin lymphoma in an oncologist network in Germany.
  9. Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.
  10. Dysfunctional Immune System Reconstitution After Rituximab Exposure In Utero.